Large gap with delayed quotes
|
Last quote
07/03/2025
-
20:20:00
|
Bid
07/03/2025 -
18:59:59
|
Bid Volume |
Ask
07/03/2025 -
18:59:59
|
Ask Volume |
|---|---|---|---|---|
|
34.66
+0.30
(
+0.87% )
|
34.61
|
200 |
34.65
|
100 |
Analysis date: 01.07.2025
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 27.05.2025.
Interest
Very weak
Very weak
One star since 24.06.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 29.04.2025 at a price of 41.29.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 25.02.2025.
4wk Rel Perf
3.37%
3.37%
The four-week dividend-adjusted overperformance versus SP500 is 3.37%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 02.05.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.84%.
Mkt Cap in $bn
3.95
3.95
With a market capitalization between $2 & $8bn, CYTOKINETICS is considered a mid-cap stock.
G/PE Ratio
0.10
0.10
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-9.92
-9.92
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
1.00%
1.00%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
73
73
For 1% of index variation, the stock varies on average by 0.73%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
12.58
12.58
The value at risk is estimated at USD 12.58. The risk is therefore 37.40%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.08.2005
31.08.2005